Thrombin – Technological development of a national biological sealant
Fabricio Klerynton Marchini, ICC – Fiocruz / PR*
Coral da Fiocruz
– Socorro Gross, PAHO*
– Arnaldo Correia de Medeiros, SVS/MoH
– Sandra de Castro Barros, SCTIE/MoH
– Marco Krieger, Fiocruz*
– Mauricio Zuma, Bio-Manguinhos*
– Akira Homma, Bio-Manguinhos*
VAC-01. Second-generation Vaccines: Adjuvants and Booster Doses
Gabrielle Gimenes Lima, USP
– Ann Ottosen, UNICEF*
– Kate O’Brian, WHO*
– Andres de Francisco, PAHO*
– Akira Homma, Bio-Manguinhos*
Chair: Mauricio Zuma, Bio-Manguinhos*
VAC-03. Recombinant influenza virus encoding a Streptococcus pneumoniae conserved antigen: a bivalent intranasal and intramuscular broad-spectrum vaccine against pneumonia and Flu
Kimberly Freitas Cardoso, Fiocruz/Instituto René Rachou
– South Africa – Caryn Fenner, Afrigen Biologics and Vaccines*
– Argentina – German Sanches, Sinergium*
– Brazil – Patricia Neves, Bio-Manguinhos*
Chair: Rami Sharf, PATH*
ORT-01. Median Tissue Culture Infectious Dose (TCID50) as a validated tool to measure antiviral activity in functionalized textiles
Adriana de Souza Azevedo Soares, Bio-Manguinhos
– Imelda Jordaan, Afrigen Biologics and Vaccines*
– Analía Acebal, Sinergium
– Gustavo Mendes, Anvisa
Chair: Jelena Berglund, PATH
